IL6 and non-small cell lung carcinoma: Having demonstrated that MSI2-deficient CAFs have limited capacities to promote NSCLC cell motility and to secrete IL-6, we postulated that MSI2 in CAFs may promote NSCLC cell motility via IL-6.